Cochrane Biased Anticoagulation Reviews:

 My feedback letters

 

1

Anticoagulation for cerebral sinus thrombosis 1

Abstract: http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD002005/frame.html

Feedback: http://www.cochranefeedback.com/cf/cda/citation.do?id=9604#9604 or http://doctormanagedcare.com/Stam.htm

 

2

Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism2 

Abstract: http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD002001/frame.html

Feedback: http://doctormanagedcare.com/vanderHeijden.htm

http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=10.1002/14651858.CD002001&reviewGroup=HM-PVD

3

Low molecular weight heparin for prevention of venous thromboembolism in patients with lower leg immobilization. (Protocol)3

Abstract: http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD006681/frame.html

Feedback: http://doctormanagedcare.com/Testroote.htm

http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=10.1002/14651858.CD006681&reviewGroup=HM-PVD or http://www.cochranefeedback.com/cf/cda/citation.do?id=9700#9700

4

Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism4

Abstract:  http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD001100/frame.html

Feedback:  http://doctormanagedcare.com/vanDongen.htm http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=10.1002/14651858.CD001100.pub2&reviewGroup=HM-PVD or http://www.cochranefeedback.com/cf/cda/citation.do?id=9000#9000

5

Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment.5

Abstract: http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD002071/frame.html

Feedback: http://doctormanagedcare.com/Dorffler.htm

http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=10.1002/14651858.CD002071.pub2&reviewGroup=HM-PVD or http://www.cochranefeedback.com/cf/cda/citation.do?id=9609#9609

6

Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery6

Abstract: http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD000535/frame.html

Feedback: http://doctormanagedcare.com/Dorffler2.htm

http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=10.1002/14651858.CD000535&reviewGroup=HM-PVD or http://www.cochranefeedback.com/cf/cda/citation.do?id=9607#9607

7

Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism7

Abstract: http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD001367/frame.html

Feedback: http://doctormanagedcare.com/Hutten.htm

http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=10.1002/14651858.CD001367.pub2&reviewGroup=HM-PVD

8

Once versus twice daily LMWH for the initial treatment of venous thromboembolism.8

Abstract: http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD003074/frame.html

 Feedback: http://doctormanagedcare.com/vanDongen2.htm

http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=10.1002/14651858.CD003074.pub2&reviewGroup=HM-PVD

9

Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures9

Abstract: http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD000305/frame.html

Feedback: http://doctormanagedcare.com/Handoll.htm

http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=10.1002/14651858.CD000305&reviewGroup=HM-MUSKINJ

10

Heparin for prevention of venous thromboembolism in general medical patients (excluding stroke and MI) (Protocol)10

Abstract: http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD003747/frame.html

Feedback: http://doctormanagedcare.com/Alikhan.htm

http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=10.1002/14651858.CD003747&reviewGroup=HM-PVD

11

Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair (Protocol)11

Abstract: http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD004179/frame.html

Feedback: http://doctormanagedcare.com/Quinlan.htm

http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=10.1002/14651858.CD004179&reviewGroup=HM-PVD

12

Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high risk patients12

Abstract: http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD005258/frame.html

Feedback: http://doctormanagedcare.com/Kakkos.htm

http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=10.1002/14651858.CD005288&reviewGroup=HM-PVD

13

Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke13

Abstract: http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD000119/frame.html

Feedback: http://doctormanagedcare.com/Sandercock.htm

http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=10.1002/14651858.CD000119.pub2&reviewGroup=HM-STROKE

14

Anticoagulants versus antiplatelet agents for acute ischaemic stroke14

Abstract: http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD003242/frame.html

Feedback: http://doctormanagedcare.com/Berge.htm

http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=10.1002/14651858.CD003242&reviewGroup=HM-STROKE

15

Anticoagulants for acute ischaemic stroke15

Abstract: http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD000024/frame.html

Feedback: http://doctormanagedcare.com/Gubitz.htm

http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=10.1002/14651858.CD000024.pub2&reviewGroup=HM-STROKE

16

Anticoagulants for preventing recurrence following presumed non-cardioembolic ischaemic stroke or transient ischaemic attack 16

Abstract: http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD000248/frame.html

Feedback: http://doctormanagedcare.com/Sandercock2.htm

http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=10.1002/14651858.CD000248&reviewGroup=HM-STROKE

17

Antiplatelet therapy for acute ischaemic stroke17

Abstract: http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD000029/frame.html

Feedback: http://doctormanagedcare.com/Sandercock3.htm

http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=10.1002/14651858.CD000029&reviewGroup=HM-STROKE

18

Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm.18

Abstract: http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD003333/frame.html

Feedback: http://doctormanagedcare.com/Lip.htm

http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=10.1002/14651858.CD003333&reviewGroup=HM-HEART

19

Anticoagulation for heart failure in sinus rhythm.19

Abstract: http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD003336/frame.html

Feedback: http://doctormanagedcare.com/Lip2.htm

http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=10.1002/14651858.CD003336&reviewGroup=HM-HEART

20

Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery20

Abstract: http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD000536/frame.html

Feedback: http://doctormanagedcare.com/Dorffler3.htm

http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=10.1002/14651858.CD000536&reviewGroup=HM-PVD

21

Anticoagulants (heparin, low molecular weight heparin and oral anticoagulants) for intermittent claudication21

Abstract: http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD001999/frame.html

 Feedback: http://doctormanagedcare.com/Cosmi.htm

http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=10.1002/14651858.CD001999&reviewGroup=HM-PVD

22

Oral anticoagulation for prolonging survival in patients with cancer22

Abstract: http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD006466/frame.html

Feedback: http://doctormanagedcare.com/Akl.htm

http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=10.1002/14651858.CD006466&reviewGroup=HM-GYNAECA

23

Anticoagulants for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischaemic attack23

Abstract: http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD000185/frame.html

Feedback: http://doctormanagedcare.com/Saxena.htm

http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=10.1002/14651858.CD000185.pub2&reviewGroup=HM-STROKE

24

Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack 24

Abstract: http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD000187/frame.html

 Feedback: http://doctormanagedcare.com/Saxena2.htm

http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=10.1002/14651858.CD000187.pub2&reviewGroup=HM-STROKE or http://www.cochranefeedback.com/cf/cda/citation.do?id=9710#9710

25

Home versus in-patient treatment for deep vein thrombosis25

Abstract: http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD003076/frame.html

Feedback: http://doctormanagedcare.com/Othieno.htm

http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=10.1002/14651858.CD003076.pub2&reviewGroup=HM-PVD or http://www.cochranefeedback.com/cf/cda/citation.do?id=9699#9699

26

Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period26

Abstract: http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD001689/frame.html

Feedback: http://doctormanagedcare.com/Gates.htm

http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=10.1002/14651858.CD001689.pub2&reviewGroup=HM-PREG

27

Heparin for pregnant women with acquired or inherited thrombophilias.27

Abstract: http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD003580/frame.html

Feedback: http://doctormanagedcare.com/Walker.htm

http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=10.1002/14651858.CD003580&reviewGroup=HM-PREG

28

Heparins and mechanical methods for thromboprophylaxis in colorectal surgery28

Abstract: http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD001217/frame.html

Feedback: http://doctormanagedcare.com/WilleJorgensen.htm

http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=10.1002/14651858.CD001217&reviewGroup=HM-PVD

29

 

Heparin versus placebo for acute coronary syndromes (Protocol)29

Abstract: http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD003462/frame.html

Feedback: http://doctormanagedcare.com/Magee.htm

http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=10.1002/14651858.CD003462&reviewGroup=HM-HEART or http://www.cochranefeedback.com/cf/cda/citation.do?id=9696#9696  

30

Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes30

Abstract: http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD002132/frame.html

Feedback: http://doctormanagedcare.com/Magee2.htm

http://www.cochranefeedback.com/cf/cda/feedback.do?DOI=10.1002/14651858.CD002132&reviewGroup=HM-HEART or http://www.cochranefeedback.com/cf/cda/citation.do?id=9697#9697

31

Heparin for ST-segment elevation myocardial infarction (Protocol).31

Abstract: http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD005349/f